|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 9.150 SEK | +7.65% |
|
+1.10% | -46.02% |
| 08-20 | Promimic AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-19 | Promimic Q1 2026 operating loss at SEK 3.5 mln | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 18.03M | - | - | - | - | - |
| 50.47B | |||||
| 44.56B | - | - | - | - | - |
| 43.08B | |||||
| 41.7B | |||||
| 33.21B |
- Stock Market
- Stocks
- PRO Stock
- Charts Promimic AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
